NihBiotechGrantPulse / compare

NUMIERA THERAPEUTICS INC vs ALLANDER BIOTECHNOLOGIES, INC.: NihBiotechGrantPulse comparison

ALLANDER BIOTECHNOLOGIES, INC.'s award of $1,210,798 is 1.0x NUMIERA THERAPEUTICS INC's $1,204,195 (90th percentile). NUMIERA THERAPEUTICS INC is dated 2026-09-14; ALLANDER BIOTECHNOLOGIES, INC. 2026-09-17.

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

Both records plus every comparable CO record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does NUMIERA THERAPEUTICS INC compare to ALLANDER BIOTECHNOLOGIES, INC.?

FieldNUMIERA THERAPEUTICS INCALLANDER BIOTECHNOLOGIES, INC.
OrganizationNUMIERA THERAPEUTICS INCALLANDER BIOTECHNOLOGIES, INC.
LocationDENVER, COAURORA, CO
ProjectTargeting Fatty Acid Oxidation with Etomoxir for the Treatment of Recurrent GlioblastomacGMP manufacturing the clinical batch of oral gel drug for treating oral mucositis in cancer patients
Project number1R44CA310352-011R44DE034643-01A1
MechanismR44R44
InstituteNational Cancer InstituteNational Institute of Dental and Craniofacial Research
Award$1,204,195$1,210,798
Awarded2026-09-142026-09-17
Project period2026-09-15 to 2028-08-312026-09-16 to 2028-08-31
UEIZCJ9M6X1Y3U7J8KMX54WRJM9
award percentile90th90th
Lab Budget Score70/10070/100
Peer rank and all 220 CO records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: NUMIERA THERAPEUTICS INC · ALLANDER BIOTECHNOLOGIES, INC.

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together